Ahead-of-print

  • HOME
  • BROWSE ARTICLES
  • Ahead-of-print

Articles in E-pub version are posted online ahead of regular printed publication.

Original Article
Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients
Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery
Received December 16, 2023  Accepted March 25, 2024  
View: 109   Download: 10
Correspondence
Both Liver Parenchymal and Non-Parenchymal Cells Express JCAD Proteins under Various Circumstances
Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu
Received March 19, 2024  Accepted March 19, 2024  
View: 148   Download: 12
Reply to: “Evaluation of the histological scoring systems of autoimmune hepatitis: a significant step towards the optimization of clinical diagnosis”
Haeryoung Kim, Sook-Hyang Jeong
Received March 14, 2024  Accepted March 16, 2024  
View: 161   Download: 5
Original Article
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
Received January 17, 2024  Accepted March 14, 2024  
View: 317   Download: 40
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after Atezolizumab/Bevacizumab Failure: A real-world study
Young Eun Chon, Dong Yun Kim, Mina Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Yeonjung Ha, Joo Ho Lee, Kwan Sik Lee, Beodeul Kang, Jung Sun Kim, Hong Jae Chon, Do Young Kim
Received December 21, 2023  Accepted March 8, 2024  
View: 370   Download: 75
Editorial
JCAD, a new potential therapeutic target in cholestatic liver disease
Byoung Kuk Jang
Received February 19, 2024  Accepted March 6, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0128    [Epub ahead of print]
View: 229   Download: 8
Letter to the Editor
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
Received March 1, 2024  Accepted March 5, 2024  
View: 335   Download: 49
Snapshot
EXAMINING THE THERAPEUTIC LANDSCAPE OF BETA-BLOCKERS IN PORTAL HYPERTENSION
Anna Brujats, Càndid Villanueva
Received February 24, 2024  Accepted March 4, 2024  
View: 192   Download: 16
Editorial
Linvencovir: Paving the way for functional cure in hepatitis B
Jiwon Yang, Jonggi Choi
Received February 26, 2024  Accepted March 4, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0149    [Epub ahead of print]
View: 228   Download: 11
Correspondence
Correspondence on Letter regarding “Toward hepatitis C virus elimination using artificial intelligence”
Ming-Ying Lu, Ming-Lung Yu
Received February 28, 2024  Accepted March 1, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0152    [Epub ahead of print]
View: 336   Download: 9
Editorial
Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma
Ji Eun Han, Hyo Jung Cho
Received February 22, 2024  Accepted February 24, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0141    [Epub ahead of print]
View: 218   Download: 14
Review
Liver Sinusoidal Endothelial Cell: An Important Yet Often Overlooked Player in the Liver Fibrosis
Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li
Received January 11, 2024  Accepted February 26, 2024  
View: 338   Download: 68
Editorial
Evaluation of the histological scoring systems of autoimmune hepatitis (AIH): A significant step towards the optimization of clinical diagnosis
Atsumasa Komori
Received February 21, 2024  Accepted February 22, 2024  
View: 217   Download: 22
Toward Hepatitis C Virus Elimination Using Artificial Intelligence
Moon Haeng Hur, Jeong-Hoon Lee
Received February 22, 2024  Accepted February 22, 2024  
View: 199   Download: 14
Correspondence
Correspondence on Editorial regarding “Identification of signature gene set as highly accurate determination of MASLD progression”
Sungju Jung, Sumin Yoon, Jong Hoon Park, Yeon-Su Lee, Kyung Hyun Yoo
Received February 22, 2024  Accepted February 22, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0136    [Epub ahead of print]
View: 214   Download: 16
Editorial
Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization
Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
Received February 16, 2024  Accepted February 20, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0116    [Epub ahead of print]
View: 399   Download: 24
Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
Chen-Te Huang, Tai-Chung Tseng
Received February 16, 2024  Accepted February 21, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0120    [Epub ahead of print]
View: 155   Download: 9
Editorial
Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
Pin-Nan Cheng, Ming-Lung Yu
Received February 14, 2024  Accepted February 16, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0115    [Epub ahead of print]
View: 187   Download: 12
Correspondence
Harnessing Hepatitis B Core-Related Antigen Measurement to Optimize Posttreatment Monitoring
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
Received February 8, 2024  Accepted February 15, 2024  
View: 115   Download: 8
Snapshot
Immunopathogenesis of liver fibrosis in steatotic liver disease
Chaerin Woo, Won-Il Jeong
Received February 13, 2024  Accepted February 14, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0113    [Epub ahead of print]
View: 206   Download: 24
Correspondence
In response to: Steatotic liver disease-know your enemies
Michael H. Le, Linda Henry, Mindie H. Nguyen
Received February 11, 2024  Accepted February 14, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0108    [Epub ahead of print]
View: 139   Download: 7
Editorial
The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective
Carlos Jose Pirola, Silvia Sookoian
Received January 31, 2024  Accepted February 2, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0082    [Epub ahead of print]
View: 273   Download: 24
Steatotic liver disease: Know your enemies
Lung-Yi Mak
Received January 30, 2024  Accepted February 1, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0078    [Epub ahead of print]
View: 202   Download: 23
Letter to the Editor
Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”
Yun-Fan Liaw
Received January 24, 2024  Accepted January 31, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0064    [Epub ahead of print]
View: 295   Download: 13
Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Tsubasa Tsutsumi, Dan Nakano, Machiko Kawaguchi, Hirokazu Takahashi, Takumi Kawaguchi
Received January 13, 2024  Accepted January 27, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0028    [Epub ahead of print]
View: 295   Download: 23
Original Article
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen
Received November 1, 2023  Accepted January 26, 2024  
View: 860   Download: 125
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression
Sumin Oh, Yang-Hyun Baek, Sungju Jung, Sumin Yoon, Byeonggeun Kang, Su-hyang Han, Gaeul Park, Je Yeong Ko, Sang-Young Han, Jin-Sook Jeong, Jin-Han Cho, Young-Hoon Roh, Sung-Wook Lee, Gi-Bok Choi, Yong Sun Lee, Won Kim, Rho Hyun Seong, Jong Hoon Park, Yeon-Su Lee, Kyung Hyun Yoo
Received November 1, 2023  Accepted January 26, 2024  
DOI: https://doi.org/10.3350/cmh.2023.0449    [Epub ahead of print]
View: 618   Download: 95
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study
Michihiro Iwaki, Hideki Fujii, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
Received December 6, 2023  Accepted January 22, 2024  
DOI: https://doi.org/10.3350/cmh.2023.0515    [Epub ahead of print]
View: 880   Download: 97
Letter to the Editor
Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
Hiroyuki Suzuki, Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Takumi Kawaguchi
Received December 23, 2023  Accepted January 17, 2024  
DOI: https://doi.org/10.3350/cmh.2023.0557    [Epub ahead of print]
View: 515   Download: 66
Original Article
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yu-Li Wang, Ya-Jun Yan, Jia Ding, Xiao Teng, Qiang Yang, Xiu-Ping Liu, Jian Wu
Received November 29, 2023  Accepted January 5, 2024  
DOI: https://doi.org/10.3350/cmh.2023.0506    [Epub ahead of print]
View: 725   Download: 108  Crossref: 1
Efficacy, safety and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients
Jinlin Hou, Edward Gane, Rozalina Balabanska, Wenhong Zhang, Jiming Zhang, Tien Huey Lim, Qing Xie, Chau-Ting Yeh, Sheng-Shun Yang, Xieer Liang, Piyawat Komolmit, Apinya Leerapun, Zenghui Xue, Ethan Chen, Yuchen Zhang, Qiaoqiao Xie, Ting-Tsung Chang, Tsung-Hui Hu, Seng Gee Lim, Wan-Long Chuang, Barbara Leggett, Qingyan Bo, Xue Zhou, Miriam Triyatni, Wen Zhang, Man-Fung Yuen
Received October 23, 2023  Accepted January 4, 2024  
View: 474   Download: 68
Review
Comprehensive Approach to Controlling Chronic Hepatitis B in China
Shan Shan, Xinyan Zhao, Jidong Jia
Received October 16, 2023  Accepted January 4, 2024  
View: 431   Download: 85
Snapshot
Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
Received December 21, 2023  Accepted December 28, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0555    [Epub ahead of print]
View: 480   Download: 48
Original Article
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Miguel Sogbe, Idoia Bilbao, Francesco P. Marchese, Jon Zazpe, Annarosaria De Vito, Marta Pozuelo, Delia D’Avola, Mercedes Iñarrairaegui, Carmen Berasain, Maria Arechederra, Josepmaria Argemi, Bruno Sangro
Received October 24, 2023  Accepted December 27, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0426    [Epub ahead of print]
View: 4413   Download: 154

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1455
TOTAL : 1737463
Close layer